» Articles » PMID: 20457763

Disease-causing Mutations in Parkin Impair Mitochondrial Ubiquitination, Aggregation, and HDAC6-dependent Mitophagy

Overview
Journal J Cell Biol
Specialty Cell Biology
Date 2010 May 12
PMID 20457763
Citations 261
Authors
Affiliations
Soon will be listed here.
Abstract

Mutations in parkin, a ubiquitin ligase, cause early-onset familial Parkinson's disease (AR-JP). How parkin suppresses parkinsonism remains unknown. Parkin was recently shown to promote the clearance of impaired mitochondria by autophagy, termed mitophagy. Here, we show that parkin promotes mitophagy by catalyzing mitochondrial ubiquitination, which in turn recruits ubiquitin-binding autophagic components, HDAC6 and p62, leading to mitochondrial clearance. During the process, juxtanuclear mitochondrial aggregates resembling a protein aggregate-induced aggresome are formed. The formation of these "mito-aggresome" structures requires microtubule motor-dependent transport and is essential for efficient mitophagy. Importantly, we show that AR-JP-causing parkin mutations are defective in supporting mitophagy due to distinct defects at recognition, transportation, or ubiquitination of impaired mitochondria, thereby implicating mitophagy defects in the development of parkinsonism. Our results show that impaired mitochondria and protein aggregates are processed by common ubiquitin-selective autophagy machinery connected to the aggresomal pathway, thus identifying a mechanistic basis for the prevalence of these toxic entities in Parkinson's disease.

Citing Articles

Regulation of HDAC6 Catalytic Activity in Cancer: The Role of Post-Translational Modifications and Protein-Protein Interactions.

Asaad L, Pepperrell B, McErlean E, Furlong F Int J Mol Sci. 2025; 26(3).

PMID: 39941046 PMC: 11818932. DOI: 10.3390/ijms26031274.


Structural basis for the pathogenicity of parkin catalytic domain mutants.

Wagner J, Sauve V, Saran A, Gehring K J Biol Chem. 2024; 301(1):108051.

PMID: 39631693 PMC: 11742612. DOI: 10.1016/j.jbc.2024.108051.


The Mechanism of Leptin Resistance in Obesity and Therapeutic Perspective.

Engin A Adv Exp Med Biol. 2024; 1460:463-487.

PMID: 39287862 DOI: 10.1007/978-3-031-63657-8_16.


Benchmarking and Automating the Biotinylation Proteomics Workflow.

Li H, Smeriglio N, Ni J, Wang Y, Sekine S, Hao L Res Sq. 2024; .

PMID: 39011118 PMC: 11247940. DOI: 10.21203/rs.3.rs-4590410/v1.


Complex interplay between RAS GTPases and RASSF effectors regulates subcellular localization of YAP.

Singh S, Bernal Astrain G, Hincapie A, Goudreault M, Smith M EMBO Rep. 2024; 25(8):3574-3600.

PMID: 39009833 PMC: 11316025. DOI: 10.1038/s44319-024-00203-9.


References
1.
Iwata A, Riley B, Johnston J, Kopito R . HDAC6 and microtubules are required for autophagic degradation of aggregated huntingtin. J Biol Chem. 2005; 280(48):40282-92. DOI: 10.1074/jbc.M508786200. View

2.
Lee J, Kim H, Ryu C, Kim J, Choi B, Lim Y . Merlin, a tumor suppressor, interacts with transactivation-responsive RNA-binding protein and inhibits its oncogenic activity. J Biol Chem. 2004; 279(29):30265-73. DOI: 10.1074/jbc.M312083200. View

3.
Zhang Y, Gao J, Chung K, Huang H, Dawson V, Dawson T . Parkin functions as an E2-dependent ubiquitin- protein ligase and promotes the degradation of the synaptic vesicle-associated protein, CDCrel-1. Proc Natl Acad Sci U S A. 2000; 97(24):13354-9. PMC: 27228. DOI: 10.1073/pnas.240347797. View

4.
Lim K, Chew K, Tan J, Wang C, Chung K, Zhang Y . Parkin mediates nonclassical, proteasomal-independent ubiquitination of synphilin-1: implications for Lewy body formation. J Neurosci. 2005; 25(8):2002-9. PMC: 6726069. DOI: 10.1523/JNEUROSCI.4474-04.2005. View

5.
Pandey U, Batlevi Y, Baehrecke E, Taylor J . HDAC6 at the intersection of autophagy, the ubiquitin-proteasome system and neurodegeneration. Autophagy. 2007; 3(6):643-5. DOI: 10.4161/auto.5050. View